Shanghai Henlius Biotech
Shanghai Henlius Biotech is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Shanghai Henlius Biotech products.
Drugs from Shanghai Henlius Biotech supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Poherdy | pertuzumab-dpzb | Oncology (Biosimilar) | HER2-positive breast cancer (Perjeta biosimilar) |
How NPP access to Shanghai Henlius Biotech products works
Reserve Meds sources Shanghai Henlius Biotech products from a US-licensed pharmaceutical wholesale partner, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Shanghai Henlius Biotech
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Shanghai Henlius Biotech.